Schedules of controlled substances: removal of naloxegol from control. Final rule.
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration removes naloxegol ((5[alpha],6[alpha])-17-allyl-6-((20-hydroxy-3,6,9,12,15,18-hexaoxaicos-1-yl)oxy)-4,5-epoxymorphinon-3,14-diol) and its salts from the schedules of the Controlled Substances Act (CSA). This scheduling action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. Prior to the effective date of this rule, naloxegol was a schedule II controlled substance because it can be derived from opium alkaloids. This action removes the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle naloxegol.
D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D007880:Legislation, Drug; D009019:Morphinans / Q000145:classification*; D009292:Narcotic Antagonists / Q000145:classification; D011092:Polyethylene Glycols / Q000145:classification*; D014481:United States
D009019:Morphinans; D009292:Narcotic Antagonists; D011092:Polyethylene Glycols